WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell® was named Winner in the Wearable Tech category at the 19th Annual SXSW Interactive Innovation Awards, held last night in Austin, TX. The Wearable Tech award honors “new hardware that revolutionizes the convenience, comfort, functionality, efficiency and fashion of having a device literally ‘on you’”. Quell was recognized for its breakthrough technology by going beyond traditional wearables that only offer tracking, to truly improving the quality of life for its users.
“We are delighted that Quell was recognized by the SXSW Interactive Innovation Awards,” said Shai N. Gozani, M.D., Ph.D. President and CEO of NeuroMetrix. "This award and other recent honors given to Quell, underscore its groundbreaking technology and the difference innovation can make in the lives of the millions of people around the world suffering from chronic pain.”
Designed to treat a wide range of chronic pain conditions, Quell was launched in June 2015 and is already having a big impact on users. In a recent clinical study, 81% of participants cited reduced pain with Quell and 67% reported a reduction in pain medication use, after 60 days.
Worn just below the knee, the patented OptiTherapy® technology in Quell delivers customizable, 100% drug free chronic pain relief to wearers, without a prescription. It is the only over-the-counter chronic pain wearable that has been FDA cleared for use while sleeping.
An updated version of Quell became available earlier this month, which gives users the option to control their therapy discreetly via mobile app. For more information about Quell or to purchase the device, please visit QuellRelief.com.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
